Effects of febrile seizures in mesial temporal lobe epilepsy with hippocampal sclerosis on gene expression using bioinformatical analysis

Yinchao Li1, Chengzhe Wang1, Pei-Ling Wang1, Li Xi1, Liemin Zhou1
1The Seventh Affiliated Hospital, Sun Yat-sen University, shenzhen, China

Tóm tắt

AbstractBackgroundTo investigate the effect of long-term febrile convulsions on gene expression in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) and explore the molecular mechanism of MTLE-HS.MethodsMicroarray data of MTLE-HS were obtained from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between MTLE-HS with and without febrile seizure history were screened by the GEO2R software. Pathway enrichment and gene ontology of the DEGs were analyzed using the DAVID online database and FunRich software. Protein–protein interaction (PPI) networks among DEGs were constructed using the STRING database and analyzed by Cytoscape.ResultsA total of 515 DEGs were identified in MTLE-HS samples with a febrile seizure history compared to MTLE-HS samples without febrile seizure, including 25 down-regulated and 490 up-regulated genes. These DEGs were expressed mostly in plasma membrane and synaptic vesicles. The major molecular functions of those genes were voltage-gated ion channel activity, extracellular ligand-gated ion channel activity and calcium ion binding. The DEGs were mainly involved in biological pathways of cell communication signal transduction and transport. Five genes (SNAP25, SLC32A1, SYN1, GRIN1,andGRIA1) were significantly expressed in the MTLE-HS with prolonged febrile seizures.ConclusionThe pathogenesis of MTLE-HS involves multiple genes, and prolonged febrile seizures could cause differential expression of genes. Thus, investigations of those genes may provide a new perspective into the mechanism of MTLE-HS.

Từ khóa


Tài liệu tham khảo

Hedrich UBS, Koch H, Becker A, Lerche H. Epileptogenesis and consequences for treatment. Nervenarzt. 2019;90(8):773–80.

Beghi E, Giussani G. Aging and the epidemiology of epilepsy. Neuroepidemiology. 2018;51(3–4):216–23.

Patterson KP, Baram TZ, Shinnar S. Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus. Neurotherapeutics. 2014;11(2):242–50.

Baulac M. MTLE with HS in adult as a syndrome. Rev Neurol (Paris). 2015;171(3):259–66.

Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–10.

Bando SY, Silva FN, Costa Lda F, Silva AV, Pimentel-Silva LR, Castro LH, et al. Complex network analysis of CA3 transcriptome reveals pathogenic and compensatory pathways in refractory temporal lobe epilepsy. PLoS One. 2013;8(11):e79913.

Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, et al. The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8(9):R183.

Pathan M, Keerthikumar S, Chisanga D, Alessandro R, Ang CS, Askenase P, et al. A novel community driven software for functional enrichment analysis of extracellular vesicles data. J Extracell Vesicles. 2017;6(1):1321455.

Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–9.

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D13.

Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431–2.

Bandettini WP, Kellman P, Mancini C, Booker OJ, Vasu S, Leung SW, et al. MultiContrast delayed enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson. 2012;14:83.

Darkins A, Polkey CE. The relationship of transient hemiparesis following febrile convulsions in infancy to subsequent temporal lobectomy for intractable seizures. J Neurol Neurosurg Psychiatry. 1985;48(6):551–5.

Harvey AS, Grattan-Smith JD, Desmond PM, Chow CW, Berkovic SF. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol. 1995;12(3):201–6.

VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol. 1998;43(4):413–26.

Heuser K, Cvancarova M, Gjerstad L, Tauboll E. Is temporal lobe epilepsy with childhood febrile seizures a distinctive entity? A comparative study. Seizure. 2011;20(2):163–6.

Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010;16(4):413–9.

Marchi N, Lerner-Natoli M. Cerebrovascular remodeling and epilepsy. Neuroscientist. 2013;19(3):304–12.

Thom M. Review: HS in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol. 2014;40(5):520–43.

Taylor PN, Han CE, Schoene-Bake JC, Weber B, Kaiser M. Structural connectivity changes in temporal lobe epilepsy: spatial features contribute more than topological measures. Neuroimage Clin. 2015;8:322–8.

Lauxmann S, Boutry-Kryza N, Rivier C, Mueller S, Hedrich UB, Maljevic S, et al. An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na(+) current. Epilepsia. 2013;54(9):e117–21.

Rozycka A, Dorszewska J, Steinborn B, Lianeri M, Winczewska-Wiktor A, Sniezawska A, et al. Association study of the 2-bp deletion polymorphism in exon 6 of the CHRFAM7A gene with idiopathic generalized epilepsy. DNA Cell Biol. 2013;32(11):640–7.

Arlier Z, Bayri Y, Kolb LE, Erturk O, Ozturk AK, Bayrakli F, et al. Four novel SCN1A mutations in Turkish patients with severe myoclonic epilepsy of infancy (SMEI). J Child Neurol. 2010;25(10):1265–8.

Hypponen J, Aikia M, Joensuu T, Julkunen P, Danner N, Koskenkorva P, et al. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study. Neurology. 2015;84(15):1529–36.

Michelucci R, Pulitano P, Di Bonaventura C, Binelli S, Luisi C, Pasini E, et al. The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behavior. 2017;68:103–7.

Skaper SD. The neurotrophin family of neurotrophic factors: an overview. Methods Mol Biol. 2012;846:1–12.

Zhu Q, Wang L, Xiao Z, Xiao F, Luo J, Zhang X, et al. Decreased expression of Ras-GRF1 in the brain tissue of the intractable epilepsy patients and experimental rats. Brain Res. 2013;1493:99–109.

Chalifoux JR, Carter AG. GABAB receptor modulation of synaptic function. Curr Opin Neurobiol. 2011;21(2):339–44.

Luscher B, Fuchs T, Kilpatrick CL. GABAA receptor trafficking-mediated plasticity of inhibitory synapses. Neuron. 2011;70(3):385–409.

Padgett CL, Slesinger PA. GABAB receptor coupling to G-proteins and ion channels. Adv Pharmacol. 2010;58:123–47.

Dejanovic B, Lal D, Catarino CB, Arjune S, Belaidi AA, Trucks H, et al. Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy. Neurobiol Dis. 2014;67:88–96.

Meng F, You Y, Liu Z, Liu J, Ding H, Xu R. Neuronal calcium signaling pathways are associated with the development of epilepsy. Mol Med Rep. 2015;11(1):196–202.

von Ruden EL, Jafari M, Bogdanovic RM, Wotjak CT, Potschka H. Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm. Neurobiol Dis. 2015;73:334–47.

Chang JY, Stamer WD, Bertrand J, Read AT, Marando CM, Ethier CR, et al. Role of nitric oxide in murine conventional outflow physiology. Am J Physiol Cell Physiol. 2015;309(4):C205–14.

Zhao N, Hashida H, Takahashi N, Sakaki Y. Cloning and sequence analysis of the human SNAP25 cDNA. Gene. 1994;145(2):313–4.

Karmakar S, Sharma LG, Roy A, Patel A, Pandey LM. Neuronal SNARE complex: a protein folding system with intricate protein-protein interactions, and its common neuropathological hallmark, SNAP25. Neurochem Int. 2019;122:196–207.

Shen XM, Selcen D, Brengman J, Engel AG. Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability. Neurology. 2014;83(24):2247–55.

Engel AG. Congenital Myasthenic syndromes in 2018. Curr Neurol Neurosci Rep. 2018;18(8):46.

Corradini I, Donzelli A, Antonucci F, Welzl H, Loos M, Martucci R, et al. Epileptiform activity and cognitive deficits in SNAP-25(+/−) mice are normalized by antiepileptic drugs. Cereb Cortex. 2014;24(2):364–76.

Wang J, Wang J, Zhang Y, Yang G, Shang AJ, Zou LP. Proteomic analysis on infantile spasm and prenatal stress. Epilepsy Res. 2014;108(7):1174–83.

Kataoka M, Kuwahara R, Matsuo R, Sekiguchi M, Inokuchi K, Takahashi M. Development- and activity-dependent regulation of SNAP-25 phosphorylation in rat brain. Neurosci Lett. 2006;407(3):258–62.

Gasnier B. The SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids. Pflugers Arch. 2004;447(5):756–9.

Jellali A, Stussi-Garaud C, Gasnier B, Rendon A, Sahel JA, Dreyfus H, et al. Cellular localization of the vesicular inhibitory amino acid transporter in the mouse and human retina. J Comp Neurol. 2002;449(1):76–87.

Williamson A, Patrylo PR, Spencer DD. Decrease in inhibition in dentate granule cells from patients with medial temporal lobe epilepsy. Ann Neurol. 1999;45(1):92–9.

Franck JE, Pokorny J, Kunkel DD, Schwartzkroin PA. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia. 1995;36(6):543–58.

Buckmaster PS. Does mossy fiber sprouting give rise to the epileptic state?[J]. Adv Exp Med Biol. 2014;813:161–8.

Hedegaard C, Kjaer-Sorensen K, Madsen LB, Henriksen C, Momeni J, Bendixen C, et al. Porcine synapsin 1: SYN1 gene analysis and functional characterization of the promoter. FEBS Open Bio. 2013;3:411–20.

Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, et al. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet. 2011;20(12):2297–307.

Li L, Chin LS, Shupliakov O, Brodin L, Sihra TS, Hvalby O, et al. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. Proc Natl Acad Sci U S A. 1995;92(20):9235–9.

Schiebler W, Jahn R, Doucet JP, Rothlein J, Greengard P. Characterization of synapsin I binding to small synaptic vesicles. J Biol Chem. 1986;261(18):8383–90.

Valtorta F, Iezzi N, Benfenati F, Lu B, Poo MM, Greengard P. Accelerated structural maturation induced by synapsin I at developing neuromuscular synapses of Xenopus laevis. Eur J Neurosci. 1995;7(2):261–70.

Barkus C, Sanderson DJ, Rawlins JN, Walton ME, Harrison PJ, Bannerman DM. What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit. Mol Psychiatry. 2014;19(10):1060–70.

Platzer K, Lemke JR. GRIN1-related neurodevelopmental disorder. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. 2019.

Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45(6):355–67.